Comment on Warren Buffett Tells Managers Their Top Priority Is To 'Zealously Guard Berkshire's Reputation'

Although the CRISPR-AI combination is still in its infancy, once it matures it is likely to be highly beneficial and could even help the world tackle climate change. During her chemistry Nobel Prize lecture in 2018, Frances Arnold said, “Today we can for all practical purposes read, write, and edit any sequence of DNA, but we cannot compose it.” That isn’t true anymore.

Biden’s Chinese tariffs could hamper e-bike sales in the U. S.—but an even bigger threat looms when a tariff exclusion expires on June 14. In May, the Biden administration slapped new tariffs on a range of Chinese goods, including a 100% levy on electric vehicles. Though few Chinese EVs are sold in the U.

NASA cited a number of risks as to why SpaceX wouldn’t be allowed to visit the 34-year-old telescope. Hubble has seen better days—and with NASA formally rejecting SpaceX’s commercial repair offer, that’s unlikely to change.

Data suggests the March headline numbers—which pointed to a very robust job market—may have been deceptively sunny. As the saying goes, “There are lies, damned lies, and statistics.”

The textile-to-textile recycling company was bought by a Swedish investment firm and has been renamed Circulose. When textile recycling company Renewcell opened its commercial factory in 2022, it was a landmark moment for circularity and sustainable fashion. That facility, housed in a paper mill in Sweden, was the first industrial-scale textile-to-textile recycling plant in the world.

Given growing access to data and advancements with AI, providers should be able to predict which patients will fare better on a specific weight loss drug. Originally developed to treat diabetes, GLP-1 agonists—now also popularly known as obesity drugs—have been making headlines for their weight-loss effects. Now, the commercial success of these GLP-1s such as Ozempic, Wegovy, Mounjaro, and Zepbound has unlocked a flurry of new research into how this blockbuster drug class may support more treatments beyond just diabetes and weight loss.